# Concomitant Utilization of Radio Frequency Energy for Atrial Fibrillation (CURE-AF) Study

> **NCT00431834** · PHASE3 · COMPLETED · sponsor: **Medtronic Cardiovascular** · enrollment: 75 (actual)

## Conditions studied

- Atrial Fibrillation

## Interventions

- **DEVICE:** Cardioblate System Surgical Ablation System
- **PROCEDURE:** Surgical RF Ablation

## Key facts

- **NCT ID:** NCT00431834
- **Lead sponsor:** Medtronic Cardiovascular
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-05
- **Primary completion:** 2010-08
- **Final completion:** 2011-08
- **Target enrollment:** 75 (ACTUAL)
- **Last updated:** 2013-11-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00431834

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00431834, "Concomitant Utilization of Radio Frequency Energy for Atrial Fibrillation (CURE-AF) Study". Retrieved via AI Analytics 2026-07-01 from https://api.ai-analytics.org/clinical/NCT00431834. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*